SEARCH

SEARCH BY CITATION

References

  • Bence N. F., Sampat R. M. and Kopito R. R. (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 15521555.
  • Burgess D. L. and Noebels J. L. (1999) Single gene defects in mice: the role of voltage-dependent calcium channels in absence models. Epilepsy Res. 36, 111122.
  • Butterfield L. H., Merino A., Golub S. H. and Shau H. (1999) From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins. Antioxid. Redox Signal. 1, 385402.
  • Carette J., Lehnert S. and Chow T. Y. (2002) Implication of PBP74/mortalin/GRP75 in the radio-adaptive response. Int. J. Radiat. Biol. 78, 183190.
  • Chevallet M., Wagner E., Luche S., Van Dorsselaer A., Leize-Wagner E. and Rabilloud T. (2003) Regeneration of peroxiredoxins during recovery after oxidative stress: only some overoxidized peroxiredoxins can be reduced during recovery after oxidative stress. J. Biol. Chem. 278, 3714637153.
  • Cohan C. S., Welnhofer E. A., Zhao L., Matsumura F. and Yamashiro S. (2001) Role of the actin bundling protein fascin in growth cone morphogenesis: localization in filopodia and lamellipodia. Cell Motil. Cytoskeleton 48, 109120.
  • Fujii J. and Ikeda Y. (2002) Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep. 7, 123130.
  • Gloor P. and Fariello R. G. (1988) Generalized epilepsy: some of its cellular mechanisms differ from those of focal epilepsy. Trends Neurosci. 11, 6368.
  • Goshima Y., Nakamura F., Strittmatter P. and Strimatter S. M. (1995) Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 376, 509514.
  • Hadari Y. R., Haring H. U. and Zick Y. (1997) p75, a member of the heat shock protein family, undergoes tyrosine phosphorylation in response to oxidative stress. J. Biol. Chem. 272, 657662.
  • Jin J., Hulette C., Wang Y., Zhang T., Pan C., Wadhwa R. and Zhang J. (2006) Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease. Mol. Cell. Proteomics 5, 11931204.
  • Kahler S. G. and Fahey M. C. (2003) Metabolic disorders and mental retardation. Am. J. Med. Genet. C Semin. Med. Genet. 117, 3141.
  • Keller A., Nesvizhskii A. I., Kolker E. and Aebersold R. (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74, 53835392.
  • Khan Z., Carey J., Park H. J., Lehar M., Lasker D. and Jinnah H. A. (2004) Abnormal motor behavior and vestibular dysfunction in the stargazer mouse mutant. Neuroscience 127, 785796.
  • Kim D., Song I., Keum S., Lee T., Jeong M. J., Kim S. S., McEnery M. W. and Shin H. S. (2001a) Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking α1G T-type Ca2+ channels. Neuron 31, 3545.
  • Kim S. H., Fountoulakis M., Cairns N. and Lubec G. (2001b) Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer’s disease and Down syndrome. J. Neural Transm. Suppl., 61, 223235.
  • Krapfenbauer K., Engidawork E., Cairns N., Fountoulakis M. and Lubec G. (2003) Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res. 967, 152160.
  • Leary L. D., Wang D., Nordli D. R. Jr, Engelstad K. and De Vivo D. C. (2003) Seizure characterization and electroencephalographic features in Glut-1 deficiency syndrome. Epilepsia 44, 701707.
  • Lee A. S. (2001) The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem. Sci. 26, 504510.
  • Letts V. A. (2005) Stargazer – a mouse to seize! Epilepsy Curr. 5, 161165.
  • Letts V. A., Felix R., Biddlecome G. H., Arikkath J., Mahaffey C. L., Valenzuela A., Bartlett F. S. 2nd, Mori Y., Campbell K. P. and Frankel W. N. (1998) The mouse stargazer gene encodes a neuronal Ca2+-channel γ subunit. Nat. Genet. 19, 340347.
  • Levine R. L., Garland D., Oliver C. N., Amici A., Climent I., Lenz A. G., Ahn B. W., Shaltiel S. and Stadtman E. R. (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186, 464478.
  • McCormack A. L., Schieltz D. M., Goode B., Yang S., Barnes G., Drubin D. and Yates J. R. 3rd (1997) Direct analysis and identification of proteins in mixtures by LC/MS/MS and database searching at the low-femtomole level. Anal. Chem. 69, 767776.
  • Meredith S. C. (2005) Protein denaturation and aggregation: cellular responses to denatured and aggregated proteins. Ann. NY Acad. Sci. 1066, 181221.
  • Niedermeyer E. (1996) Primary (idiopathic) generalized epilepsy and underlying mechanisms. Clin. Electroencephalogr. 27, 121.
  • Pappolla M. A., Omar R. A., Kim K. S. and Robakis N. K. (1992) Immunohistochemical evidence of antioxidant stress in Alzheimer’s disease. Am. J. Pathol. 140, 621628.
  • Pascual J. M., Wang D., Hinton V., Engelstad K., Saxena C. M., Van Heertum R. L. and De Vivo D. C. (2007) Brain glucose supply and the syndrome of infantile neuroglycopenia. Arch. Neurol. 64, 507513.
  • Pearce R. K., Owen A., Daniel S., Jenner P. and Marsden C. D. (1997) Alterations in the distribution of glutathione in the substantia nigra in Parkinson’s disease. J. Neural Transm. 104, 661677.
  • Perez Velazquez J. L., Huo J. Z., Dominguez L. G., Leshchenko Y. and Snead Iii O. C. (2007) Typical versus atypical absence seizures: network mechanisms of the spread of paroxysms. Epilepsia 48, 15851593.
  • Powers W. J., Videen T. O., Markham J., McGee-Minnich L., Antenor-Dorsey J. V., Hershey T. and Perlmutter J. S. (2007) Selective defect of in vivo glycolysis in early Huntington’s disease striatum. Proc. Natl Acad. Sci. USA 104, 29452949.
  • Rabilloud T., Heller M., Gasnier F., Luche S., Rey C., Aebersold R., Benahmed M., Louisot P. and Lunardi J. (2002) Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J. Biol. Chem. 277, 1939619401.
  • Ryu M. J., Kim D., Kang U. B., Kim J., Shin H. S., Lee C. and Yu M. H. (2007) Proteomic analysis of γ-butyrolactone-treated mouse thalamus reveals dysregulated proteins upon absence seizure. J. Neurochem. 102, 646656.
  • Song I., Kim D., Choi S., Sun M., Kim Y. and Shin H. S. (2004) Role of the α1G T-type calcium channel in spontaneous absence seizures in mutant mice. J. Neurosci. 24, 52495257.
  • Steriade M. and Contreras D. (1995) Relations between cortical and thalamic cellular events during transition from sleep patterns to paroxysmal activity. J. Neurosci. 15, 623642.
  • Tonge R., Shaw J., Middleton B., Rowlinson R., Rayner S., Young J., Pognan F., Hawkins E., Currie I. and Davison M. (2001) Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 1, 377396.
  • Vockley J., Rogan P. K., Anderson B. D., Willard J., Seelan R. S., Smith D. I. and Liu W. (2000) Exon skipping in IVD RNA processing in isovaleric acidemia caused by point mutations in the coding region of the IVD gene. Am. J. Hum. Genet. 66, 356367.
  • Wagner E., Luche S., Penna L., Chevallet M., Van Dorsselaer A., Leize-Wagner E. and Rabilloud T. (2002) A method for detection of overoxidation of cysteines: peroxiredoxins are oxidized in vivo at the active-site cysteine during oxidative stress. Biochem. J. 366, 777785.
  • Wang L. H. and Strittmatter S. M. (1996) A family of rat CRMP genes is differentially expressed in the nervous system. J. Neurosci. 16, 61976207.
  • Yang K. S., Kang S. W., Woo H. A., Hwang S. C., Chae H. Z., Kim K. and Rhee S. G. (2002) Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J. Biol. Chem. 277, 3802938036.
  • Zabel C., Sagi D., Kaindl A. M., Steireif N., Klare Y., Mao L., Peters H., Wacker M. A., Kleene R. and Klose J. (2006) Comparative proteomics in neurodegenerative and non-neurodegenerative diseases suggest nodal point proteins in regulatory networking. J. Proteome Res. 5, 19481958.
  • Zanata S. M., Lopes M. H., Mercadante A. F. et al. (2002) Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J. 21, 33073316.
  • Zemlan F. P., Thienhaus O. J. and Bosmann H. B. (1989) Superoxide dismutase activity in Alzheimer’s disease: possible mechanism for paired helical filament formation. Brain Res. 476, 160162.